Published in Blood on June 15, 1996
Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses. Haematologica (2009) 0.90
Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling. Mol Immunol (2008) 0.86
Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes. Cancer Immunol Immunother (2010) 0.84
Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells. PLoS One (2012) 0.81
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia (2006) 2.40
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J (1998) 2.30
Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature (1985) 2.29
Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother (2001) 2.24
Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones. Nature (1984) 1.96
Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol (2008) 1.90
Rearrangement and expression of the alpha, beta, and gamma chain T cell receptor genes in human thymic leukemia cells and functional T cells. J Exp Med (1986) 1.62
Theta-frequency bursting and resonance in cerebellar granule cells: experimental evidence and modeling of a slow k+-dependent mechanism. J Neurosci (2001) 1.62
Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells. Transplantation (2000) 1.60
Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol (1998) 1.44
Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA D and with 50 per cent penetrance. N Engl J Med (1977) 1.33
Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med (1993) 1.31
Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J Immunol (1998) 1.30
Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest (1998) 1.30
aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J Exp Med (1986) 1.27
Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res (1973) 1.23
T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J Immunol (1999) 1.17
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Editorial. Anthropology and genetic markers. Hum Immunol (2001) 1.14
DRw determinants on human T cells primed against allogeneic lymphocytes. Transplant Proc (1978) 1.12
T cell recognition of allopeptides in context of syngeneic MHC. J Immunol (1992) 1.11
Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit Rev Immunol (1993) 1.09
Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol (1993) 1.08
Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol (1974) 1.07
T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules. J Exp Med (1992) 1.06
Presence of T-cell receptor mRNA in functionally distinct T cells and elevation during intrathymic differentiation. Nature (1984) 1.05
[Glanders--a comprehensive review]. Dtsch Tierarztl Wochenschr (2006) 1.05
Inhibition of cellular mediated immunity in marihuana smokers. Science (1974) 1.05
Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J Immunol (1993) 1.03
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01
Inhibitory synaptic plasticity: spike timing-dependence and putative network function. Front Neural Circuits (2013) 1.01
Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci U S A (1983) 1.00
The HLA system in the families of patients with juvenile diabetes mellitus. J Exp Med (1976) 0.98
VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Diabetes Obes Metab (2008) 0.97
Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. J Immunol (1989) 0.96
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96
Effect of recipient gender and race on heart and kidney allograft survival. Transplant Proc (1992) 0.95
Letter: Cellular immune responsiveness in cigarette smokers. Lancet (1974) 0.94
Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med (1987) 0.94
Juvenile diabetes mellitus and the HLA system. Transplant Proc (1979) 0.94
Functional significance of polymorphism among MHC class II gene promoters. Tissue Antigens (1996) 0.94
Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture. J Exp Med (1982) 0.93
MHC class II binding of peptides derived from HLA-DR 1. J Immunol (1992) 0.92
Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci U S A (1988) 0.92
Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. Transpl Immunol (2008) 0.92
Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma. Br J Haematol (2001) 0.91
Immunological monitoring of heart allograft recipients. Transplant Proc (1987) 0.91
Tuberculosis outbreak in a dromedary racing herd and rapid serological detection of infected camels. Vet Microbiol (2007) 0.91
New perspectives on immunointervention in autoimmune diseases. Immunol Today (1990) 0.90
The efficacy of a live Listeria monocytogenes combined serotype 1/2a and serotype 4b vaccine. Vaccine (1995) 0.90
Foot and mouth disease and similar virus infections in camelids: a review. Rev Sci Tech (2012) 0.90
Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation (1996) 0.89
CD8(+)CD28(-) T suppressor cells represent a distinct subset in a heterogeneous population. Transplant Proc (2001) 0.89
Mechanism of liver allograft rejection: the indirect recognition pathway. Hum Immunol (1997) 0.89
Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum Immunol (1999) 0.88
Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. Hum Immunol (1998) 0.88
A late-differentiation antigen associated with the helper inducer function of human T cells. Nature (1986) 0.88
Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. Blood (1997) 0.88
Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice (human/murine SCID arthritis). J Autoimmun (1999) 0.88
Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol (1995) 0.88
Outbreak of microsporidiosis caused by Enterocytozoon bieneusi in falcons. Vet Parasitol (2007) 0.88
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl Immunol (2007) 0.88
Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages. J Immunol (1987) 0.87
Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant (1992) 0.87
New approaches to specific immunomodulation in transplantation. Int Rev Immunol (1996) 0.86
Anti-idiotypic antibodies to HLA-DR4 and DR2. J Immunol (1983) 0.86
Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens. Nature (1984) 0.86
Development and clinical evaluation of a PCR assay targeting the metalloprotease gene (mprA) of B. pseudomallei. Zoonoses Public Health (2007) 0.86
New HLA-D alleles associated with DR1 and DR2. Tissue Antigens (1981) 0.86
Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance. Immunol Res (1989) 0.86
Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells. Am J Transplant (2006) 0.86
Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc (1993) 0.85
Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1, 2)-fucosyltransferase. J Biol Chem (1999) 0.84
Polymorphism of HLA in the Romanian population. Tissue Antigens (1992) 0.84
Intra-HLA recombinations in juvenile diabetes mellitus. Diabete Metab (1977) 0.83
An outbreak in Italy of botulism associated with a dessert made with mascarpone cream cheese. Eur J Epidemiol (2000) 0.83
Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation (1999) 0.83
Protein kinase Cθ is required for cardiomyocyte survival and cardiac remodeling. Cell Death Dis (2010) 0.82
Evidence that HLA-D is different from DR and that two different HLA loci code for B-cell antigens. Transplant Proc (1979) 0.82
Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Vox Sang (2008) 0.82
Alloreactive T cells: expression of HLA-D antigens, stimulation of autologous MLR, and possible immunoregulatory function. Hum Immunol (1981) 0.82
TCR repertoire of suppressor CD8+CD28- T cell populations. Hum Immunol (1999) 0.82
Glyoxalase 1: a possible 'null' allele. Hum Hered (1979) 0.82
Antigen presenting cells integrate opposing signals from CD4+ and CD8+ regulatory T lymphocytes to arbitrate the outcomes of immune responses. Hum Immunol (1999) 0.82
Cloning and functional characterization of the 5'-regulatory region of the human CD86 gene. Hum Immunol (2000) 0.82